Patents by Inventor Shengqiang PAN
Shengqiang PAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240361432Abstract: This application discloses a LiDAR anti-interference method and apparatus, a storage medium, and a LiDAR. The method is applied to a LiDAR, and the LiDAR includes a laser emission array and a laser receiving array. The method includes determining at least two laser emission units to be turned on in a measurement period, controlling the at least two laser emission units to emit laser beams based on a preset rule, and controlling respectively corresponding laser receiving units of the at least two laser emission units to receive echo beams, to detect a target object. The at least two laser emission units to be turned on are in different laser emission groups, and the at least two laser emission units to be turned on satisfy a physical condition of no optical crosstalk.Type: ApplicationFiled: July 5, 2024Publication date: October 31, 2024Applicant: SUTENG INNOVATION TECHNOLOGY CO., LTD.Inventors: Yajun DU, Shengqiang PAN
-
Patent number: 12092760Abstract: This application discloses a LiDAR anti-interference method and apparatus, a storage medium, and a LiDAR. The method is applied to a LiDAR, and the LiDAR includes a laser emission array and a laser receiving array. The method includes determining at least two laser emission units to be turned on in a measurement period, controlling the at least two laser emission units to emit laser beams based on a preset rule, and controlling respectively corresponding laser receiving units of the at least two laser emission units to receive echo beams, to detect a target object. The at least two laser emission units to be turned on are in different laser emission groups, and the at least two laser emission units to be turned on satisfy a physical condition of no optical crosstalk.Type: GrantFiled: December 22, 2022Date of Patent: September 17, 2024Assignee: SUTENG INNOVATION TECHNOLOGY CO., LTD.Inventors: Yajun Du, Shengqiang Pan
-
Publication number: 20240295658Abstract: The present disclosure provides a laser emitting module and a LiDAR apparatus. The laser emitting module includes at least two groups of laser emitting circuits. Each group of the laser emitting circuits includes one charging energy storage circuit and at least one energy releasing circuit. The energy releasing circuit includes an energy releasing switch and at least one laser. The energy releasing switch is turned on to drive at least one laser to work correspondingly. The charging energy storage circuit and the energy releasing circuit are arranged one-to-one or one-to-multiple. Any two adjacent emissions correspond to different groups of the laser emitting circuits.Type: ApplicationFiled: May 13, 2024Publication date: September 5, 2024Applicant: SUTENG INNOVATION TECHNOLOGY CO., LTD.Inventor: Shengqiang PAN
-
Patent number: 12013462Abstract: The present disclosure provides a laser emitting module and a LiDAR apparatus. The laser emitting module includes at least two groups of laser emitting circuits. Each group of the laser emitting circuits includes one charging energy storage circuit and at least one energy releasing circuit. The energy releasing circuit includes an energy releasing switch and at least one laser. The energy releasing switch is turned on to drive at least one laser to work correspondingly. The charging energy storage circuit and the energy releasing circuit are arranged one-to-one or one-to-multiple. Any two adjacent emissions correspond to different groups of the laser emitting circuits.Type: GrantFiled: December 28, 2022Date of Patent: June 18, 2024Assignee: SUTENG INNOVATION TECHNOLOGY CO., LTD.Inventors: Shengqiang Pan, Yanchao Li
-
Patent number: 11940561Abstract: The present disclosure relates to a laser receiving device and a LiDAR. An isolation component is provided between a plurality of parallel sensor groups, and an isolation component is provided between a plurality of amplifier groups in parallel, so that a plurality of parallel receiving channels each form an independent current loop, thereby reducing noise crosstalk among signal receiving channels and improving the signal-to-noise ratio of the laser receiving device.Type: GrantFiled: December 14, 2021Date of Patent: March 26, 2024Assignee: SUTENG INNOVATION TECHNOLOGY CO.,LTD.Inventors: Yanmin Li, Zhen Zhang, Shengqiang Pan
-
Publication number: 20230204783Abstract: The present disclosure provides a laser emitting module and a LiDAR apparatus. The laser emitting module includes at least two groups of laser emitting circuits. Each group of the laser emitting circuits includes one charging energy storage circuit and at least one energy releasing circuit. The energy releasing circuit includes an energy releasing switch and at least one laser. The energy releasing switch is turned on to drive at least one laser to work correspondingly. The charging energy storage circuit and the energy releasing circuit are arranged one-to-one or one-to-multiple. Any two adjacent emissions correspond to different groups of the laser emitting circuits.Type: ApplicationFiled: December 28, 2022Publication date: June 29, 2023Applicant: SUTENG INNOVATION TECHNOLOGY CO., LTD.Inventors: Shengqiang PAN, Yanchao LI
-
Publication number: 20230204725Abstract: This application discloses a LiDAR anti-interference method and apparatus, a storage medium, and a LiDAR. The method is applied to a LiDAR, and the LiDAR includes a laser emission array and a laser receiving array. The method includes determining at least two laser emission units to be turned on in a measurement period, controlling the at least two laser emission units to emit laser beams based on a preset rule, and controlling respectively corresponding laser receiving units of the at least two laser emission units to receive echo beams, to detect a target object. The at least two laser emission units to be turned on are in different laser emission groups, and the at least two laser emission units to be turned on satisfy a physical condition of no optical crosstalk.Type: ApplicationFiled: December 22, 2022Publication date: June 29, 2023Applicant: SUTENG INNOVATION TECHNOLOGY CO., LTD.Inventors: Yajun DU, Shengqiang PAN
-
Publication number: 20220107394Abstract: The present disclosure relates to a laser receiving device and a LiDAR. An isolation component is provided between a plurality of parallel sensor groups, and an isolation component is provided between a plurality of amplifier groups in parallel, so that a plurality of parallel receiving channels each form an independent current loop, thereby reducing noise crosstalk among signal receiving channels and improving the signal-to-noise ratio of the laser receiving device.Type: ApplicationFiled: December 14, 2021Publication date: April 7, 2022Applicant: SUTENG INNOVATION TECHNOLOGY CO., LTD.Inventors: Yanmin LI, Zhen ZHANG, Shengqiang PAN
-
Patent number: 10562910Abstract: A nitrogen-containing tricyclic compound which acts as modulator of FXR, or a stereoisomer, a geometric isomer, a tautomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, and the use of the compound for the treatment of disease and/or condition mediated by FXR are described. And a pharmaceutical composition containing the compound disclosed herein and a method of treatment of disease and/or condition mediated by FXR comprising administering the compound or the pharmaceutical composition thereof are also described.Type: GrantFiled: August 2, 2017Date of Patent: February 18, 2020Assignee: NORTH & SOUTH BROTHER PHARMACY INVESTMENT COMPANY LIMITEDInventors: Xiaojun Wang, Xinye Yang, Junwen Wu, Shaohui Xiong, Shengqiang Pan, Shengtian Cao, Yingjun Zhang
-
Publication number: 20190169203Abstract: A nitrogen-containing tricyclic compound which acts as modulator of FXR, or a stereoisomer, a geometric isomer, a tautomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, and the use of the compound for the treatment of disease and/or condition mediated by FXR are described. And a pharmaceutical composition containing the compound disclosed herein and a method of treatment of disease and/or condition mediated by FXR comprising administering the compound or the pharmaceutical composition thereof are also described.Type: ApplicationFiled: August 2, 2017Publication date: June 6, 2019Applicant: SUNSHINE LAKE PHARMA CO., LTD.Inventors: Xiaojun WANG, Xinye YANG, Junwen WU, Shaohui XIONG, Shengqiang PAN, Shengtian CAO, Yingjun ZHANG
-
Patent number: 10183917Abstract: The present invention relates to novel tricyclic compounds which can bind to FXR and act as modulators of the FXR, or a stereoisomer, a geometric isomer, a tautomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, and the uses of the compounds for the treatment of diseases and/or conditions mediated by FXR. The invention further provides a pharmaceutical composition containing the compound disclosed herein and a method of treatment of diseases and/or conditions mediated by FXR comprising administering the compound or the pharmaceutical composition.Type: GrantFiled: February 5, 2016Date of Patent: January 22, 2019Assignee: SUNSHINE LAKE PHARMA CO., LTD.Inventors: Xiaojun Wang, Xinye Yang, Shengqiang Pan, Rui Guo, Junwen Wu, Yingjun Zhang, Changchung Cheng
-
Publication number: 20180030003Abstract: The present invention relates to novel tricyclic compounds which can bind to FXR and act as modulators of the FXR, or a stereoisomer, a geometric isomer, a tautomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, and the uses of the compounds for the treatment of diseases and/or conditions mediated by FXR. The invention further provides a pharmaceutical composition containing the compound disclosed herein and a method of treatment of diseases and/or conditions mediated by FXR comprising administering the compound or the pharmaceutical composition.Type: ApplicationFiled: February 5, 2016Publication date: February 1, 2018Applicant: Sunshine Lake Pharma Co., Ltd.Inventors: Xiaojun WANG, Xinye YANG, Shengqiang PAN, Rui GUO, Junwen WU, Yingjun ZHANG, Changchung CHENG